Ignite Creation Date:
2024-05-06 @ 5:41 PM
Last Modification Date:
2024-10-26 @ 2:33 PM
Study NCT ID:
NCT05391126
Status:
RECRUITING
Last Update Posted:
2023-10-10
First Post:
2022-05-20
Brief Title:
GENOCARE A Prospective Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
Sponsor:
Reema A Patel
Organization:
University of Kentucky
Study Overview
Official Title:
GENOCARE A Prospective Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective randomized study designed to compare genotype-guided dosing to usual care in patients with pancreas cancer and colorectal cancer who are UGT1A1 intermediate metabolizers 128 heterozygotes and usual UGT metabolizers 11 All patients will be assessed for UGT1A1 genotype at screening and those with intermediate or usual UGT1A1 genotypes 128 11 will be randomized to genotype-guided dosing versus usual care
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None